Entrepreneur-in-Residence, Value-Based Care, Roivant Health at Roivant Sciences

New York, New York, United States

Roivant Sciences Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, BiotechnologyIndustries

Requirements

  • Exceptional academic background
  • Proven track record of successfully founding and growing a tech-enabled healthcare services or technology

Responsibilities

  • Bring forward, ideate, and refine a concept for a technology-enabled platform or service within the value-based care landscape
  • Lead early opportunity validation, including unmet need assessment, stakeholder interviews, data analysis, and early go-to-market planning
  • Build critical partnerships with health plans/payers, provider groups, and other risk-bearing entities to test, refine, and scale your solution
  • Collaborate closely with Roivant’s operating partners, product leaders, and healthcare experts to develop the business model and execution plan
  • Lead early hiring and company formation efforts, with a transition toward CEO responsibilities as the company is launched
  • Drive commercialization strategies and initial revenue generation efforts for new initiatives, focusing on scalable and sustainable growth, particularly through contracting and sales to health plans and other risk-bearing organizations
  • Provide strategic insights and market intelligence from the value-based care and payer landscape to inform new venture development and existing portfolio company strategies

Skills

Key technologies and capabilities for this role

Value-Based CareHealthcare InnovationEntrepreneurshipBiotechDrug DevelopmentHealth Technology

Questions & Answers

Common questions about this position

Is this a full-time position?

Yes, this is a full-time role designed for entrepreneurial leaders who are ready to found and lead a new Roivant Health company.

What is the salary or compensation for this role?

This information is not specified in the job description.

What skills and qualities are required for the Entrepreneur-in-Residence role?

The role requires being ambitious, entrepreneurial, comfortable with ambiguity, passionate about building transformational healthcare businesses, and embracing calculated risk-taking. Responsibilities include ideating concepts in value-based care, leading opportunity validation with stakeholder interviews and data analysis, and building partnerships.

What is the company culture like at Roivant Sciences?

Roivant promotes an open and collaborative culture, embraces diversity across all dimensions, fosters inclusivity where employees feel valued and empowered, and supports rapid career advancement for high performers with flexible role design.

What makes a strong candidate for this Entrepreneur-in-Residence position?

Strong candidates are motivated entrepreneurial leaders with diverse backgrounds, ready to found and lead a new company in value-based care, comfortable with ambiguity, and experienced in ideating, validating opportunities, and building partnerships in healthcare technology.

Roivant Sciences

Develops biopharmaceuticals and RNA therapeutics

About Roivant Sciences

Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates in the biopharmaceutical market, which involves creating drugs from biological sources. Roivant's unique business model combines in-house development with strategic partnerships, allowing it to build a strong pipeline of drug candidates and utilize advanced technologies to meet medical needs. A key subsidiary, Genevant, specializes in RNA therapeutics, employing proprietary delivery platforms for mRNA, RNAi, and gene editing to treat specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.

New York City, New YorkHeadquarters
2014Year Founded
$1,750.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options

Risks

Integration challenges from Dermavant acquisition may disrupt operations and delay development.
Regulatory hurdles in Pulmovant collaboration with Bayer could impede progress.
Failure of lupus drug brepocitinib may lead to financial losses and investor concerns.

Differentiation

Roivant Sciences focuses on late-stage drug candidates, reducing development time and cost.
The company builds Vants, nimble biotech firms, to enhance drug development efficiency.
Roivant leverages RNA therapeutics, including mRNA and RNAi, for innovative treatments.

Upsides

Roivant's acquisition of Dermavant expands its dermatology portfolio and therapeutic areas.
Strategic partnerships with Bayer and Roche accelerate drug development and market entry.
Increased investment from financial institutions highlights confidence in Roivant's growth potential.

Land your dream remote job 3x faster with AI